2025. Formulation and optimization of liquisolid tablet for improving the dissolution profile of rivaroxaban by using DoE approachand antithrombic activity. Journal of Carcinogenesis. 23, 1 (Oct. 2025), 701–719. DOI:https://doi.org/10.64149/J.Carcinog.24.3s.812-830.